Thus, Nox2 activation in diabetes can results in the development of diabetic retinopathy via many different pathways including damaging the mitochondria by elevating ROS, breaking down blood-retina barrier and increasing leukostasis [64,65]. Here, CYBB is linked to diabetic retinopathy.